Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer

Clinical trial NCT05371197 · UNKNOWN

Trial details

NCT number: NCT05371197
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Mismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)Neoadjuvant Therapy

Start date: 2022-05-05
Primary completion: 2024-06-30
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.